Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure

Comparison of CD146 +/− mesenchymal stem cells in improving premature ovarian failure

Abstract Background Mesenchymal stem cells (MSCs) are a heterogeneous group of subpopulations with differentially expressed surface markers. CD146 + MSCs correlate with high therapeutic and secretory potency. However, their therapeutic efficacy and mechanisms in premature ovarian failure (POF) have...

Full description

Bibliographic Details
Main Authors: Lin Zhang, Yang Sun, Xiao-Xu Zhang, Yu-Bin Liu, Hui-Yan Sun, Chu-Tse Wu, Feng-Jun Xiao, Li-Sheng Wang
Format: Article
Language:English
Published: BMC 2022-06-01
Series:Stem Cell Research & Therapy
Subjects:
UC-CD146 +/− MSCs
POF
Immune regulation
Online Access:https://doi.org/10.1186/s13287-022-02916-x

Similar Items

Similar Items